Bulgarian Organization for Medicines Verification to be established

4 September 2015

At a recent official ceremony, five organizations signed a Memorandum of Understanding regarding the establishment of a Bulgarian Organization for Medicines Verification (BgMVO).

The organizations-founders of the BgMVO are the Association of Research-Based Pharmaceutical Manufacturers in Bulgaria, the Bulgarian Generic Pharmaceutical Association, the Bulgarian Association for Development of Parallel Trade with Medicines, the Bulgarian Association of Pharmaceutical Wholesalers and the Bulgarian Pharmaceutical Union.

In the fall, representatives of the stakeholders will start consultations for the creation of the BgMVO that will be responsible for implementation and monitoring of the system. The goal is in the beginning of 2018, Bulgaria to have functioning medicines verification system, which will be synchronized with the European one and would guarantee that no falsified medicines will reach the patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical